Results 161 to 170 of about 510,425 (296)

A Second Parathyroid Hormone? [PDF]

BMJ, 1963
C N, CRUICKSHANK, E A, FAIRBURN, M D, TROTTER   +2 more
openaire   +2 more sources

Multiple sites of synthesis and action of parathyroid hormone-related protein

, 1995
Multiple sites of synthesis and action of parathyroid hormone-related ...
JA Danks (16107110), TJ Martin (15477635), V Paspaliaris (18467229), E Williams (11760059), MT Gillespie (15875351), JM Moseley (15876185)   +5 more
core  

Beyond biologic sex: Exploratory insights into the heterogeneity of hormonal and contextual drivers of periodontal and peri‐implant outcomes

Periodontology 2000, EarlyView.
Abstract Background Periodontal and peri‐implant diseases are multifactorial inflammatory conditions influenced by microbial, host, hormonal, genetic, and behavioral factors. Although sex‐based differences in immune and inflammatory responses are well recognized in medicine, the extent to which biologic sex and hormonal status influence the prevalence,
Caitlin Neapole, Mark Gettas, Roberto Farina, Yvonne Hernandez‐Kapila   +3 more
wiley   +1 more source

The Economics of Intraoperative Parathyroid Hormone Monitoring for Parathyroid Surgery: A Scoping Review of Cost Analyses and Economic Evaluations. [PDF]

Laryngoscope Investig Otolaryngol
Staibano P, Bhandari M, Parmar A, Han J, Shahid S, Au M, Pasternak JD, Yeo C, Xie F, Almquist M, Parpia S, Rogers A, Busse JW, Orloff L, Seib C, Nguyen NT, Thabane A, McKechnie T, Young JE, Zhang H.   +19 more
europepmc   +1 more source

Bioassay of Parathyroid Hormone.

Experimental Biology and Medicine, 1953
B L, RUBIN, R I, DORFMAN
openaire   +2 more sources

Antiresorptive therapy influence on peri‐implant diseases: Clinical implications and osteoimmunological perspectives

Periodontology 2000, EarlyView.
Abstract Background/Aim Antiresorptive therapy represents a cornerstone in the management of osteoporosis and cancer‐related bone disease through suppression of osteoclast‐mediated bone resorption. As implant therapy becomes more common in aging populations, clinicians increasingly encounter patients receiving these medications, thus making their ...
Emilio A. Cafferata, Frank Schwarz, Reinhard Gruber   +2 more
wiley   +1 more source

Prognostic Value of Parathyroid Hormone in Heart Failure with Reduced Ejection Fraction. [PDF]

J Clin Med
Genç A, Yılmaz Öztekin GM, Uslu Ş, Avcı R.   +3 more
europepmc   +1 more source

Pathologic Characterization and Clinical Significance of Lymphovascular Invasion in Canine Thyroid Carcinomas

Veterinary and Comparative Oncology, EarlyView.
ABSTRACT The association between lymphovascular invasion (LVI) and outcomes in dogs with thyroid carcinoma is inadequately described, and a standardized definition of LVI is lacking. This study's objectives were to histopathologically and immunohistochemically characterize LVI and to evaluate associated clinical outcomes in dogs with thyroid carcinoma.
Maureen A. Griffin, Brianna Stoyle, Allie Oakes, Brian Flesner, Jennifer A. Lenz, Darko Stefanovski, Amy C. Durham   +6 more
wiley   +1 more source

Progression of coronary artery calcification in chronic kidney disease: nonlinear associations with serum magnesium and parathyroid hormone. [PDF]

Front Med (Lausanne)
Chen Y, Qiu W, Shu Y, Lu L, Luo Y.
europepmc   +1 more source

Molecular pathophysiology of chronic kidney disease–mineral and bone disorder: Focus on the fibroblast growth factor 23–Klotho axis and bone turnover dynamics

Experimental Physiology, EarlyView.
Abstract Chronic kidney disease–mineral and bone disorder (CKD‐MBD) is a major complication of chronic kidney disease (CKD), characterized by disruptions in mineral metabolism, abnormal bone turnover and vascular calcification, which collectively increase the risk of fractures and cardiovascular disease.
Alief Waitupu, Laras Pratiwi, Henry Sutanto, Djoko Santoso, Decsa Medika Hertanto   +4 more
wiley   +1 more source